These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9824602)

  • 1. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.
    Jeppesen PB; Staun M; Tjellesen L; Mortensen PB
    Gut; 1998 Dec; 43(6):763-9. PubMed ID: 9824602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omeprazole on intestinal output in the short bowel syndrome.
    Nightingale JM; Walker ER; Farthing MJ; Lennard-Jones JE
    Aliment Pharmacol Ther; 1991 Aug; 5(4):405-12. PubMed ID: 1777549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jejunal efflux in short bowel syndrome.
    Nightingale JM; Lennard-Jones JE; Walker ER; Farthing MJ
    Lancet; 1990 Sep; 336(8718):765-8. PubMed ID: 1976145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.
    Francisco MP; Wagner MH; Sherman JM; Theriaque D; Bowser E; Novak DA
    J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):79-83. PubMed ID: 12142815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.
    Ladefoged K; Christensen KC; Hegnhøj J; Jarnum S
    Gut; 1989 Jul; 30(7):943-9. PubMed ID: 2668129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis].
    Kim JW; Kim HS; Lee DK; Suk KT; Kim JM; Baik SK; Kwon SO; Cho MY
    Korean J Gastroenterol; 2004 Mar; 43(3):153-9. PubMed ID: 15034285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intravenous omeprazole on non-variceal upper gastrointestinal bleeding after endoscopic treatment: a comparative study.
    Këlliçi I; Kraja B; Mone I; Prifti S
    Med Arh; 2010; 64(6):324-7. PubMed ID: 21218747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.
    Ley LM; Becker A; Lühmann R; Sander P; Lücker PW
    Methods Find Exp Clin Pharmacol; 2005; 27(1):25-9. PubMed ID: 15834456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.
    Szkudlarek J; Jeppesen PB; Mortensen PB
    Gut; 2000 Aug; 47(2):199-205. PubMed ID: 10896910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
    Klein CE; Chiu YL; Cai Y; Beck K; King KR; Causemaker SJ; Doan T; Esslinger HU; Podsadecki TJ; Hanna GJ
    J Clin Pharmacol; 2008 May; 48(5):553-62. PubMed ID: 18440920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
    Merki HS; Wilder-Smith CH
    Gastroenterology; 1994 Jan; 106(1):60-4. PubMed ID: 8276209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.
    Seguy D; Vahedi K; Kapel N; Souberbielle JC; Messing B
    Gastroenterology; 2003 Feb; 124(2):293-302. PubMed ID: 12557135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
    Yeomans ND; Tulassay Z; Juhász L; Rácz I; Howard JM; van Rensburg CJ; Swannell AJ; Hawkey CJ
    N Engl J Med; 1998 Mar; 338(11):719-26. PubMed ID: 9494148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers.
    Schöller-Gyüre M; Kakuda TN; De Smedt G; Vanaken H; Bouche MP; Peeters M; Woodfall B; Hoetelmans RM
    Br J Clin Pharmacol; 2008 Oct; 66(4):508-16. PubMed ID: 18492125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.